Tissue Repair with a Therapeutic Transcription Factor
- 1 October 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 11 (15) , 2143-2158
- https://doi.org/10.1089/104303400750001444
Abstract
The healing of tissue involves a wide range of molecular, cellular, and physiological events that are coordinated in a temporally specific manner. The cellular transcription factor early growth response factor 1 (Egr1) is expressed minutes after acute injury and serves to stimulate the production of a class of growth factors whose role is to promote tissue repair. We have studied the effects of Egr-1 expression at the site of dermal wounding in rodents. We find that Egr-1 promotes angiogenesis in vitro and in vivo, increases collagen production, and accelerates wound closure. These results show that Egr-1 gene therapy accelerates the normal healing process and raises the potential use of this therapeutic transcription factor for any aspect of tissue repair.Keywords
This publication has 50 references indexed in Scilit:
- Determination of growth factor and receptor levels in human skin from wound borders: implications for gene therapy to accelerate wound healingInternational Journal of Experimental Pathology, 2008
- Delivery and Expression of Fluid Shear Stress-Inducible Promoters to the Vessel Wall: Applications for Cardiovascular Gene TherapyHuman Gene Therapy, 1999
- Vascular Smooth Muscle Cells Express the Transcriptional Corepressor NAB2 in Response to InjuryThe American Journal of Pathology, 1999
- NAB2: A Transcriptional Brake for Activated Gene Expression in the Vessel Wall?The American Journal of Pathology, 1999
- Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double‐blind, placebo‐controlled studyWound Repair and Regeneration, 1999
- Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway.Journal of Clinical Investigation, 1998
- Transcriptional Repression of Human Insulin-Like Growth Factor-II P4 Promoter by Wilms' Tumor Suppressor WT1DNA and Cell Biology, 1996
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- Formation of Healing Tissue and Angiogenesis in Repair of Connective Tissue Stimulated by Epidermal Growth FactorScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1994
- Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factorJournal of Vascular Surgery, 1992